Entry Details |
ID |
|
430 |
Source Database |
|
UniProtKB/Swiss-Prot |
UniProtKB/Swiss-Prot Accession Number |
|
P16382 (Created: 1990-08-01 Updated: 2008-12-16) |
UniProtKB/Swiss-Prot Entry Name |
|
IL4RA_MOUSE |
Protein Name |
|
Interleukin-4 receptor alpha chain |
Gene |
|
Il4r |
Organism Scientific |
|
Mus musculus |
Organism Common |
|
Mouse |
Lineage |
|
Eukaryota Metazoa Chordata Craniata Vertebrata Euteleostomi Mammalia Eutheria Euarchontoglires Glires Rodentia Sciurognathi Muroidea Muridae Murinae Mus
|
Protein Length [aa] |
|
810 |
Protein Mass [Da] |
|
87627 |
Features |
|
Type | Description | Status | Start | End | signal peptide | | | 1 | 25 | chain | Interleukin-4 receptor alpha chain | | 26 | 810 | chain | Soluble interleukin-4 receptor alpha chain | | 26 | 0 | disulfide bond | | by similarity | 34 | 44 | disulfide bond | | by similarity | 75 | 87 | transmembrane region | | potential | 234 | 257 | topological domain | Extracellular | potential | 26 | 233 | topological domain | Cytoplasmic | potential | 258 | 810 | domain | Fibronectin type-III | | 124 | 220 | region of interest | Required for IRS1 activation and IL4- induced cell growth | by similarity | 441 | 557 | region of interest | Required for IL4-induced gene expression | by similarity | 557 | 653 | modified residue | Phosphotyrosine | | 500 | 500 | modified residue | Phosphotyrosine | probable | 575 | 575 | modified residue | Phosphotyrosine | probable | 603 | 603 | modified residue | Phosphotyrosine | probable | 631 | 631 | glycosylation site | N-linked (GlcNAc...) | potential | 72 | 72 | glycosylation site | N-linked (GlcNAc...) | potential | 129 | 129 | glycosylation site | N-linked (GlcNAc...) | potential | 135 | 135 | glycosylation site | N-linked (GlcNAc...) | | 163 | 163 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J; reduced IL4-neutralizing capacity of soluble form) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | sequence variant | (in strain: BALB/c, AKR/J, SJL/ J) | | 0 | 0 | splice variant | (in isoform 2) | | 0 | 0 | splice variant | (in isoform 2) | | 231 | 810 | splice variant | (in isoform 3) | | 258 | 810 | compositionally biased region | Poly-Glu | | 376 | 381 | compositionally biased region | Poly-Glu | | 527 | 530 | short sequence motif | WSXWS motif | | 213 | 217 | short sequence motif | Box 1 motif | | 263 | 271 | short sequence motif | ITIM motif | | 707 | 712 |
|
SP Length |
|
25 |
| | ----+----1----+----2----+----3----+----4----+----5 |
Signal Peptide | | MGRLCTKFLTSVGCLILLLVTGSGS |
Sequence | | MGRLCTKFLTSVGCLILLLVTGSGSIKVLGEPTCFSDYIRTSTCEWFLDS AVDCSSQLCLHYRLMFFEFSENLTCIPRNSASTVCVCHMEMNRPVQSDRY QMELWAEHRQLWQGSFSPSGNVKPLAPDNLTLHTNVSDEWLLTWNNLYPS NNLLYKDLISMVNISREDNPAEFIVYNVTYKEPRLSFPINILMSGVYYTA RVRVRSQILTGTWSEWSPSITWYNHFQLPLIQRLPLGVTISCLCIPLFCL FCYFSITKIKKIWWDQIPTPARSPLVAIIIQDAQVPLWDKQTRSQESTKY PHWKTCLDKLLPCLLKHRVKKKTDFPKAAPTKSLQSPGKAGWCPMEVSRT VLWPENVSVSVVRCMELFEAPVQNVEEEEDEIVKEDLSMSPENSGGCGFQ ESQADIMARLTENLFSDLLEAENGGLGQSALAESCSPLPSGSGQASVSWA CLPMGPSEEATCQVTEQPSHPGPLSGSPAQSAPTLACTQVPLVLADNPAY RSFSDCCSPAPNPGELAPEQQQADHLEEEEPPSPADPHSSGPPMQPVESW EQILHMSVLQHGAAAGSTPAPAGGYQEFVQAVKQGAAQDPGVPGVRPSGD PGYKAFSSLLSSNGIRGDTAAAGTDDGHGGYKPFQNPVPNQSPSSVPLFT FGLDTELSPSPLNSDPPKSPPECLGLELGLKGGDWVKAPPPADQVPKPFG DDLGFGIVYSSLTCHLCGHLKQHHSQEEGGQSPIVASPGCGCCYDDRSPS LGSLSGALESCPEGIPPEANLMSAPKTPSNLSGEGKGPGHSPVPSQTTEV PVGALGIAVS |
Original | | MGRLCTKFLTSVGCLILLLVTGSGSIKVLGEPTCFSDYIRTSTCEWFLDS AVDCSSQLCLHYRLMFFEFSENLTCIPRNSASTVCVCHMEMNRPVQSDRY QMELWAEHRQLWQGSFSPSGNVKPLAPDNLTLHTNVSDEWLLTWNNLYPS NNLLYKDLISMVNISREDNPAEFIVYNVTYKEPRLSFPINILMSGVYYTA RVRVRSQILTGTWSEWSPSITWYNHFQLPLIQRLPLGVTISCLCIPLFCL FCYFSITKIKKIWWDQIPTPARSPLVAIIIQDAQVPLWDKQTRSQESTKY PHWKTCLDKLLPCLLKHRVKKKTDFPKAAPTKSLQSPGKAGWCPMEVSRT VLWPENVSVSVVRCMELFEAPVQNVEEEEDEIVKEDLSMSPENSGGCGFQ ESQADIMARLTENLFSDLLEAENGGLGQSALAESCSPLPSGSGQASVSWA CLPMGPSEEATCQVTEQPSHPGPLSGSPAQSAPTLACTQVPLVLADNPAY RSFSDCCSPAPNPGELAPEQQQADHLEEEEPPSPADPHSSGPPMQPVESW EQILHMSVLQHGAAAGSTPAPAGGYQEFVQAVKQGAAQDPGVPGVRPSGD PGYKAFSSLLSSNGIRGDTAAAGTDDGHGGYKPFQNPVPNQSPSSVPLFT FGLDTELSPSPLNSDPPKSPPECLGLELGLKGGDWVKAPPPADQVPKPFG DDLGFGIVYSSLTCHLCGHLKQHHSQEEGGQSPIVASPGCGCCYDDRSPS LGSLSGALESCPEGIPPEANLMSAPKTPSNLSGEGKGPGHSPVPSQTTEV PVGALGIAVS |
| | ----+----1----+----2----+----3----+----4----+----5 |
Hydropathies |
|
|
|
|